Inhibitory effects of Rubi Fructus extracts on hepatic steatosis development in high-fat diet-induced obese mice

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1821-1827

  Nam, Mi Kyung ^a   Choi, Hye Ran ^a   Cho, Jin Sook ^b   Cho, Soo Min ^a   Ha, Ki Chan ^c   Kim, Tae Hyeon ^d   Ryu, Hee Young ^a   Lee, Young Ik ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Lee's Biotech Co   (South Korea)

^c Healthcare Claims and Management Incorp ^*  (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

Hepatic steatosis; High fat diet; Lipogenic enzyme; Lipogenic gene; Liver lipotoxicity; Rubi fructus

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CHOLESTEROL; FATTY ACID SYNTHASE; HIGH DENSITY LIPOPROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; FATTY LIVER; FRUIT; GENE EXPRESSION; GENETICS; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; RUBUS;

ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CHOLESTEROL; DIET, HIGH-FAT; FATTY ACID SYNTHASES; FATTY LIVER; FRUIT; GENE EXPRESSION; LEPTIN; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PLANT EXTRACTS; RUBUS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 84924219964     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2398     Document Type: Article

References (33)

1. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N and Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923, 2003. (Pubitemid 36397405)
2. Schreuder TC, Verwer BJ, van Nieuwkerk CM and Mulder CJ: Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 14: 2474-2486, 2008. (Pubitemid 352037734)
3. Kotronen A and Yki-Järvinen H: Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 27-38, 2008.
4. Edmison J and McCullough AJ: Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 11: 75-104, 2007. (Pubitemid 46829977)
5. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G and Melchionda N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850, 2001. (Pubitemid 33641605)
6. Varela-Rey M, Embade N, Ariz U, Lu SC, Mato JM and Martinez-Chantar ML: Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol 41: 969-976, 2009.
7. Nepokroeff CM, Lakshmanan MR and Porter JW: Fatty-acid synthase from rat liver. Methods Enzymol 35: 37-44, 1975.
8. Targher G, Bertolini I, Rodella S, Zoppini G, Lippi G, Day C and Muggeo M: Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 51: 444-450, 2008.
9. Unger RH, Clark GO, Scherer PE and Orci L: Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801: 209-214, 2010.
10. Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L and Colin P: Ursodeoxycholic acid for treatment of nonalcoholic steatosis steatohepatitis: results of a randomized trial. Hepatology 39: 770-778, 2004. (Pubitemid 38337657)
11. Sgro C and Escousse A: Side effects of fibrates (except liver and muscle). Therapie 46: 351-354, 1991 (In French).
12. Cha HW, Park MS and Park KM: Physiological activities of Rubus coreanus Miquel. Korean J Food Sci Tech 33: 409-415, 2001.
13. Yang HM, Oh SM, Lim SS, Shin HK, Oh YS and Kim JK: Antiinflammatory activities of Rubus coreanus depend on the degree of fruit ripening. Phytother Res 22: 102-107, 2008.
14. Oh MS, Yang WM, Chang MS, Park W, Kim do R, Lee HK, Kim WN and Park SK: Effect of Rubus coreanus on sperm parameters and cAMP responsive element modulator (CREM) expression in rat testes. J Ethnopharmacol 114: 463-467, 2007. (Pubitemid 350026215)
15. Lee MW: Phenolic compounds from the leaves of Rubus coreanus. Yakhak Hoeji 39: 200-204, 1995.
16. Perry LM: Medicinal plants of east and southeast Asia, attributed properties and uses. MIT press, Cambridge, MA, pp346-356, 1980.
17. Sohn DW, Kim HY, Kim SD, Lee EJ, Kim HS, Kim JK, Hwang SY, Cho YH and Kim SW: Elevation of intracavernous pressure and NO-cGMP activity by a new herbal formula in penile tissues of spontaneous hypertensive male rats. J Ethnopharmacol 120: 176-180, 2008.
18. Lee YI, Choi SK, Yang JY, Cho JS and Kim TH: Hepatoprotective activities of Rubus coreanus depends on the degree of ripening. Natural Product Sciences 15: 156-161, 2009.
19. Lee YI, Whang KE, Cho JS, Ahn BM, Lee SB, Dong MS and Kim TH: Rubus coreanus extract attenuates acetaminophen induced hepatotoxicity; involvement of cytochrome P450 3A4. Biomol Ther 17: 455-460, 2009.
20. Hwang JM, Cho JS, Kim TH and Lee YI: Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species. Biomed Pharmacother 64: 264-270, 2010.
21. Kang EH, Kown TY, Oh GT, Park WF, Park SI, Park SK and Lee YI: The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen. Antiviral Res 72: 100-106, 2006. (Pubitemid 44349016)
22. Kaul A and Khanduja KL: Plant polyphenols inhibit benzoyl peroxide-induced superoxide anion radical production and diacylglyceride formation in murine peritoneal macrophages. Nutr Cancer 35: 207-211, 1999. (Pubitemid 30115134)
23. Folch J, Lees M and Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
24. Hulcher FH and Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 14: 625-631, 1973.
25. Markwell MA, McGroarty EJ, Bieber LL and Tolbert NE: The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J Biol Chem 248: 3426-3432, 1973.
26. Angulo P: Nonalcoholic fatty liver disease. N Eng J Med 346: 1221-1231, 2002.
27. Dixon JB, Bhathal PS and O'Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121: 91-100, 2001. (Pubitemid 32591518)
28. Zelcer N and Tontonoz P: Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116: 607-614, 2006. (Pubitemid 43326865)
29. Horton JD, Goldstein JL and Brown MS: SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131, 2002. (Pubitemid 34496588)
30. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ and Moller DE: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001. (Pubitemid 32995375)
31. Liu H, Li J, Zhao W, Bao L, Song X, Xia Y, Wang X, Zhang C, Wang X, Yao X and Li M: Fatty acid synthase inhibitors from Geum japonicum Thunb. var. chinense. Chem Biodivers 6: 402-410, 2009.
32. Meyer AS, Heinonen M and Frankel EN: Antioxidant interactions of catechin, cyanidin, caffeic acid, quercetin and ellagic acid on human LDL oxidation. Food Chem 61: 71-75, 1998. (Pubitemid 28152160)
33. Yu YM, Chang WC, Wu CH and Chiang SY: Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem 16: 675-681, 2005. (Pubitemid 41456710)